These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38349405)

  • 1. Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy.
    Li J; Ma A; Zhang R; Chen Y; Bolyard C; Zhao B; Wang C; Pich T; Li W; Sun N; Ma Q; Wen H; Clinton SK; Carson WE; Li Z; Xin G
    Cancer Immunol Immunother; 2024 Feb; 73(3):52. PubMed ID: 38349405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Hierarchically Biomimetic Iron Oxide Nanosystems for Macrophage Repolarization-Promoted Immune Checkpoint Blockade of Cancer Immunotherapy.
    Kang Y; Yan J; Han X; Wang X; Wang Y; Song P; Su X; Rauf A; Jin X; Pu F; Zhang H
    ACS Appl Mater Interfaces; 2024 Jul; 16(28):36131-36141. PubMed ID: 38979627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia.
    Wei L; Tokizane K; Konishi H; Yu HR; Kiyama H
    J Neuroinflammation; 2017 Oct; 14(1):198. PubMed ID: 28974234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
    Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
    Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxycarboxylic acid receptor 3 and GPR84 - Two metabolite-sensing G protein-coupled receptors with opposing functions in innate immune cells.
    Peters A; Rabe P; Liebing AD; Krumbholz P; Nordström A; Jäger E; Kraft R; Stäubert C
    Pharmacol Res; 2022 Feb; 176():106047. PubMed ID: 34968686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHISA3 Reprograms Tumor-Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy.
    Zhang S; Yu B; Sheng C; Yao C; Liu Y; Wang J; Zeng Q; Mao Y; Bei J; Zhu B; Chen S
    Adv Sci (Weinh); 2024 Sep; 11(36):e2403019. PubMed ID: 39054639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages.
    Recio C; Lucy D; Purvis GSD; Iveson P; Zeboudj L; Iqbal AJ; Lin D; O'Callaghan C; Davison L; Griesbach E; Russell AJ; Wynne GM; Dib L; Monaco C; Greaves DR
    Front Immunol; 2018; 9():1419. PubMed ID: 29973940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming.
    Zeng W; Li F; Jin S; Ho PC; Liu PS; Xie X
    J Exp Clin Cancer Res; 2023 Sep; 42(1):245. PubMed ID: 37740232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.
    Chen X; Zhou J; Wang Y; Wang X; Chen K; Chen Q; Huang D; Jiang R
    Oncogene; 2024 Aug; 43(33):2517-2530. PubMed ID: 39004633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor.
    Suzuki M; Takaishi S; Nagasaki M; Onozawa Y; Iino I; Maeda H; Komai T; Oda T
    J Biol Chem; 2013 Apr; 288(15):10684-91. PubMed ID: 23449982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
    Ramesh A; Malik V; Brouillard A; Kulkarni A
    J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma.
    Shao G; Cui X; Wang Y; Luo S; Li C; Jiang Y; Cai D; Li N; Li X
    CNS Neurosci Ther; 2024 Jul; 30(7):e14791. PubMed ID: 38997808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy.
    Li Y; Yi J; Ma R; Wang Y; Lou X; Dong Y; Cao Y; Li X; Wang M; Dang X; Li R; Lei N; Song H; Qin Z; Yang W
    J Control Release; 2024 Sep; 373():447-462. PubMed ID: 39038546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-phagocytic function and structural basis of GPR84 signaling.
    Zhang X; Wang Y; Supekar S; Cao X; Zhou J; Dang J; Chen S; Jenkins L; Marsango S; Li X; Liu G; Milligan G; Feng M; Fan H; Gong W; Zhang C
    Nat Commun; 2023 Sep; 14(1):5706. PubMed ID: 37709767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.
    Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G
    J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma.
    Kim J; Kim TJ; Chae S; Ha H; Park Y; Park S; Yoon CJ; Lim SA; Lee H; Kim J; Kim J; Im K; Lee K; Kim J; Kim D; Lee E; Shin MH; Park SI; Rhee I; Jung K; Lee J; Lee KH; Hwang D; Lee KM
    Mol Cancer; 2024 Feb; 23(1):45. PubMed ID: 38424542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.